Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer
Part of paid clinical trials in Buffalo, New York.
- Sponsor
- Roswell Park Cancer Institute
- Study ID
- NCT05787834
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Best Practice — OTHERReceive usual care
- Medical Device Usage and Evaluation — OTHERWear accelerometer
- Respiratory Muscle Training — PROCEDUREUndergo RMT
- Survey Administration — OTHERAncillary studies
Study Details
This clinical trial evaluates whether home-based respiratory muscle training is useful for minimizing side effects in patients undergoing treatment for cancer. Over-activation of the nervous system during breast cancer treatment can result in heart- and lung-related side effects which have the potential to reduce a patient's quality of life. Aerobic exercise can help prevent the development of these side effects. However, engaging in regular aerobic exercise may be difficult for breast cancer patients who are actively undergoing treatment. Respiratory muscle training (RMT) involves a series of breathing and other exercises that are performed to improve the function of the respiratory muscles through resistance and endurance training. Home-based RMT may represent a more feasible approach for reducing side effects in patients undergoing treatment for breast cancer.
Key Dates
- Start date
- Oct 16, 2023
- Status verified
- May 2026
- Primary completion
- Oct 16, 2028
- Completion
- Oct 16, 2029
Study Design
- Enrollment
- 130 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: Group I (low resistance RMT Group)Patients receive usual care for 12 weeks on study and a Respiratory Muscle training Device with small breathing resistance
- Experimental: Group II (Moderate to highter resistance RMT)Patients undergo RMT using a respiratory muscle training device with moderate to higher breathing resistance for 12 weeks on study.
Primary Outcome Measure
Proportion of patients who participate in the study [ Time Frame: Up to 12 weeks ]
Central Contacts
- ASK RPCI1-877-275-7724
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | Ellis Levine, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Buffalo, NY
Related Studies
- Lung Cancer Biomarkers and ScreeningRecruiting · NYU Langone Health · New York, New York
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With PathologyRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®PHASE2 · Recruiting · CivaTech Oncology · New York, New York